###begin article-title 0
###xml 14 27 14 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLIMP1/PRMT5 </italic>
Expression of BLIMP1/PRMT5 and concurrent histone H2A/H4 arginine 3 dimethylation in fetal germ cells, CIS/IGCNU and germ cell tumors
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 128 135 128 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 379 385 <span type="species:ncbi:10090">murine</span>
###xml 577 582 <span type="species:ncbi:10090">mouse</span>
Most testicular germ cell tumors arise from intratubular germ cell neoplasia unclassified (IGCNU, also referred to as carcinoma in situ), which is thought to originate from a transformed primordial germ cell (PGC)/gonocyte, the fetal germ cell. Analyses of the molecular profile of IGCNU and seminoma show similarities to the expression profile of fetal germ cells/gonocytes. In murine PGCs, expression and interaction of Blimp1 and Prmt5 results in arginine 3 dimethylation of histone H2A and H4. This imposes epigenetic modifications leading to transcriptional repression in mouse PGCs enabling them to escape the somatic differentiation program during migration, while expressing markers of pluripotency.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 133 138 <span type="species:ncbi:9606">human</span>
###xml 222 227 <span type="species:ncbi:9606">human</span>
In the present study, we show that BLIMP1 and PRMT5 were expressed and arginine dimethylation of histones H2A and H4 was detected in human male gonocytes at weeks 12-19 of gestation, indicating a role of this mechanism in human fetal germ cell development as well. Moreover, BLIMP1/PRMT5 and histone H2A and H4 arginine 3 dimethylation was present in IGCNU and most seminomas, while downregulated in embryonal carcinoma (EC) and other nonseminomatous tumors.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 85 91 <span type="species:ncbi:10090">murine</span>
###xml 96 101 <span type="species:ncbi:9606">human</span>
These data reveal similarities in marker expression and histone modification between murine and human PGCs. Moreover, we speculate that the histone H2A and H4 arginine 3 dimethylation might be the mechanism by which IGCNU and seminoma maintain the undifferentiated state while loss of these histone modifications leads to somatic differentiation observed in nonseminomatous tumors.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 316 317 316 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 380 388 380 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 394 440 394 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">intratubular germ cell neoplasia unclassified </italic>
###xml 575 576 575 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 725 726 725 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 820 827 820 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OCT3/4 </italic>
###xml 831 837 831 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NANOG </italic>
###xml 865 866 865 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 867 869 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 216 219 <span type="species:ncbi:9606">man</span>
In males aged 15 - 34 years, type II testicular germ cell tumors (TGCT), i.e. seminomas and nonseminomas, are the most common malignancies with fatal outcome [1] accounting for up to 60% of all malignancies in young man. The incidence of this type of cancer has been steadily increasing throughout the last decades [2]. The tumors arise from a neoplastic precursor, the carcinoma in situ (CIS)/intratubular germ cell neoplasia unclassified (IGCNU) and develop into seminoma and/or nonseminoma (including embryonal carcinoma, teratomas, yolk sac tumors and choriocarcinomas) [3]. The IGCNU lesions are believed to arise by delayed or blocked maturation of primordial germ cells (PGC)/gonocytes during early fetal development [4]. The recently identified markers for IGCNU and seminoma, namely the markers of pluripotency OCT3/4 and NANOG further support this model [5-10].
###end p 9
###begin p 10
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1282 1288 1282 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HoxB1 </italic>
###xml 1289 1291 1289 1291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1653 1655 1653 1655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 132 138 <span type="species:ncbi:10090">murine</span>
###xml 143 148 <span type="species:ncbi:9606">human</span>
###xml 653 657 <span type="species:ncbi:10090">mice</span>
###xml 1436 1442 <span type="species:ncbi:10090">murine</span>
Expression of pluripotency genes is detected in embryonic stem cells (ES) and the inner cell mass of the early embryo. Additionally murine and human ES cells need to be cultured in the presence of factors inhibiting differentiation, although there are species specific differences [11,12]. In PGCs, early gonocytes and IGCNU as well as seminoma lesions some of these markers of pluripotency are expressed, although differences have been reported [13,14]. According to the current model, PGCs actively suppress somatic differentiation programs by epigenetic modifications, a mechanism which might also account for IGCNU and seminoma [15]. Recent data in mice demonstrate that suppression of somatic differentiation programs in PGCs is mediated by a complex of two proteins, Blimp1 (B-Lymphocyte induced maturation protein-1; PRDM1) and Prmt5 (protein arginine methyltransferase-5). Upon arrival in the genital ridge the PGCs differentiate to become gonocytes and the Blimp1/Prmt5 complex is translocated in the cytoplasm and subsequently, Blimp1 is downregulated. Targeted deletion of Blimp1 leads to loss of PGCs short after specification due to differentiation. The Blimp1-deficient PGCs display an insufficient repression of markers indicative for somatic differentiation such as HoxB1 [16]. Blimp1 is a transcriptional repressor harboring an N-terminal PR-SET domain, 5 zinc-finger domains and an acidic domain at the C-terminus. In murine PGCs the Blimp1/Prmt5 complex mediates symmetrical methylation of histones H2A and H4 at arginine 3 (H2AR3me2s, H4R3me2s), resulting in widespread epigenetic modification leading to transcriptional repression [17].
###end p 10
###begin p 11
###xml 76 81 <span type="species:ncbi:9606">human</span>
###xml 156 161 <span type="species:ncbi:9606">human</span>
###xml 276 281 <span type="species:ncbi:9606">human</span>
In the present study, we investigated the expression of BLIMP1/PRMT5 during human fetal germ cell development and in testicular germ cell tumors. Analyzing human fetal tissues, we found BLIMP1/PRMT5 colocalized in gonocytes at weeks 12 - 19 of pregnancy, supporting a role in human germ cell development. Furthermore BLIMP1/PRMT5 is expressed in IGCNU and seminoma, but downregulated in nonseminomatous GCTs. Since the nuclear localization of BLIMP1 correlated with the presence of the histone modifications H2AR3me2s and H4R3me2, our data help in explaining the undifferentiated/fetal state of IGCNU and seminoma.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
Normal germ cell development
###end title 13
###begin p 14
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 514 517 514 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 606 607 606 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 671 674 671 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 878 880 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 901 903 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 921 923 921 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1213 1215 1213 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1294 1296 1294 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 1451 1453 1451 1453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E</xref>
###xml 1458 1460 1458 1460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2F</xref>
###xml 1594 1596 1594 1596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2G</xref>
###xml 1628 1630 1628 1630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1640 1642 1640 1642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2H</xref>
###xml 1720 1722 1720 1722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2I</xref>
###xml 1777 1779 1777 1779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2K</xref>
###xml 1805 1807 1805 1807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2L</xref>
###xml 1897 1899 1897 1899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2M</xref>
###xml 2115 2117 2115 2117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 10 16 <span type="species:ncbi:10090">murine</span>
###xml 44 50 <span type="species:ncbi:10090">murine</span>
###xml 369 374 <span type="species:ncbi:9606">human</span>
###xml 408 413 <span type="species:ncbi:9606">human</span>
###xml 483 488 <span type="species:ncbi:9606">human</span>
###xml 1062 1068 <span type="species:ncbi:10090">murine</span>
###xml 1965 1969 <span type="species:ncbi:10090">mice</span>
Data from murine embryos indicate, that the murine homologs of BLIMP1 and PRMT5, are expressed in PGCs from specification on up to their arrival in the genital ridge [16,17]. Short thereafter, these cells differentiate to become gonocytes and the Blimp1/Prmt5 complex is translocated in the cytoplasm and subsequently, Blimp1 is downregulated. In order to test whether human BLIMP1 and PRMT5 are detected in human fetal PGCs/gonocytes, immunohistochemical analyses were performed on human fetal material. On the 12th week of pregnancy migrating gonocytes coexpressing PRMT5 and BLIMP1 were detected, (Fig. 1, compare A to B, merged in C, arrows). Next, testes from the 19th week of pregnancy were analyzed. By this time gonocytes gradually differentiate into prespermatogonia and migrate towards the periphery of the emerging seminiferous tubules to settle down in their niche [18]. Both BLIMP1 (Fig. 2A) and PRMT5 (Fig. 2B) were detected at this stage in gonocytes. PRMT5, in contrast to BLIMP1, was detected both in the nucleus and in the cytoplasm. Since the murine Blimp1/Prmt5 complex has been described to mediate symmetrical dimethylation of arginine 3 on histone H2A and/or H4 tails (H2AR3me2s/H4R3me2s) [17] immunohistochemical analysis to detect this modification was performed (Fig. 2D). Co-staining of PRMT5 revealed that the cells displaying high nuclear levels of PRMT5 are in fact positive for the H2AR3me2s/H4R3me2s histone mark (Fig. 2E and 2F, merged). To further analyze the population of cells expressing BLIMP1 we performed double labeling experiments using BLIMP1 (Figure 2G) and the gonocytal markers M2A[19] (Figure 2H). BLIMP1/M2A double positive signals were detected in most gonocytes (Figure 2I, arrows). Double labeling for H2AR3me2s/H4R3me2s (Fig 2K) combined with M2A (Fig. 2L) showed, that the M2A positive gonocytes displayed H2AR3me2s/H4R3me2s modifications (Fig 2M). Again, these findings were in accordance with the situation in mice, where the Blimp1 protein is downregulated and the H2AR3me2s/H4R3me2s methylation is gradually lost when germ cells proceed to prespermatogonia [17].
###end p 14
###begin p 15
###xml 27 30 27 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 0 47 0 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Human fetal gonocytes at 12<sup>th </sup>week of pregnancy</bold>
###xml 88 91 88 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 61 66 <span type="species:ncbi:9606">human</span>
Human fetal gonocytes at 12th week of pregnancy. Sections of human fetal gonocytes at 12th week of pregnancy subjected to antibody staining towards BLIMP1 (A), PRMT5 (B) and overlay (C). D and E no primary antibody controls. Arrows indicate exemplary germ cells. Bar = 50 mum.
###end p 15
###begin p 16
###xml 27 30 27 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 0 47 0 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Human fetal gonocytes at 19<sup>th </sup>week of pregnancy</bold>
###xml 88 91 88 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 149 150 149 150 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 161 162 161 162 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 172 173 172 173 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 203 204 203 204 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 214 215 214 215 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 237 238 237 238 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 278 279 278 279 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 289 290 289 290 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 306 307 306 307 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I</bold>
###xml 335 336 335 336 <bold xmlns:xlink="http://www.w3.org/1999/xlink">K</bold>
###xml 358 359 358 359 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L</bold>
###xml 367 368 367 368 <bold xmlns:xlink="http://www.w3.org/1999/xlink">M</bold>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 61 66 <span type="species:ncbi:9606">human</span>
Human fetal gonocytes at 19th week of pregnancy. Sections of human fetal gonocytes at 19th week of pregnancy subjected to antibody staining towards (A) BLIMP1, (B) PRMT5, (C) Merge of BLIMP1 and PRMT5, (D) PRMT5, (E) methylated H2A/H4, (F) merge of PRMT5 and methylated H2A/H4 (G) BLIMP1 (H) M2A antigen, (I) merge of BLIMP1 and M2A, (K) methylated H2A/H4, (L) M2A, (M) merge of methylated H2A/H4 and M2A.
###end p 16
###begin p 17
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 10 16 <span type="species:ncbi:10090">murine</span>
###xml 215 220 <span type="species:ncbi:9606">human</span>
Since the murine Blimp1/Prmt5 complex was specifically detected in early germ cells but not in prespermatogonia[16] we next asked whether PRMT5, BLIMP1 and dimethylated histone H2A and H4 could be detected in adult human testes. BLIMP1 was detected in the cytoplasm of round spermatids (Fig. 3A, arrow) and PRMT5 was found in the nuclei and in the cytoplasm of spermatocytes (Fig. 3B arrow) and round spermatids (Fig. 3B black arrowhead). H2AR3me2s/H4R3me2s modification is detected in type A spermatogonia (Fig. 3C red arrowhead), as well as round and elongated spermatids, (Fig. 3C arrow). The cytoplasmatic localization of BLIMP1 in adult testes excludes the functional interaction with PRMT5 and the resulting epigenetic modification. This implicates an alternative mechanism of H2AR3me2s/H4R3me2s modification in adult testes.
###end p 17
###begin p 18
###xml 0 18 0 18 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Human adult testis</bold>
###xml 78 79 78 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 89 90 89 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 137 138 137 138 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 141 145 141 145 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 365 366 365 366 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 535 536 535 536 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 668 671 668 671 <bold xmlns:xlink="http://www.w3.org/1999/xlink">lu </bold>
###xml 705 708 705 708 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Le </bold>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 39 44 <span type="species:ncbi:9606">human</span>
Human adult testis. Sections of normal human adult testis stained for BLIMP1 (A), PRMT5 (B) methylated and dimethylated histones H2A/H4 (C). (A) A seminiferous tubule is shown with normal spermatogenesis. Spermatogonia, spermatocytes, and Sertoli cells are devoid of the staining, while nuclear and cytoplasmatic staining occurs in round spermatids (large arrow). (B) Staining with PRMT5 antibody shows low expression of PRMT5 in the nuclei of spermatocytes (arrowhead), and strong nuclear staining in round spermatids (large arrow). (C) Positive staining with Me H2A/H4 occurs in spermatogonia (red arrowheads) and round spermatids (arrow), but not in spermatocytes. lu lumen of the seminiferous tubule; Le Leydig Cells.
###end p 18
###begin title 19
Type II TGCTs
###end title 19
###begin p 20
###xml 107 108 107 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4E</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4F</xref>
###xml 457 459 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4G</xref>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4H</xref>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4I</xref>
###xml 968 969 968 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
We next examined various TGCTs for the presence of BLIMP1/PRMT5 and H2AR3me2s/H4R3me2s. As shown in Figure 4, IGCNU show nuclear BLIMP1 staining (Fig. 4A), cytoplasmatic PRMT5 staining (Fig. 4B) and dimethylation of H2A/H4 (Fig. 4C). Seminomas show predominant nuclear BLIMP1 signal (Fig. 4D) sparse nuclear PRMT5 signal (Fig. 4E) as well as a strong and homogenous signal for H2AR3me2s/H4R3me2s (Fig 4F). In embryonal carcinoma, expression of BLIMP1 (Fig. 4G) and PRMT5 (Fig. 4H) was weak and cytoplasmatic. As expected, histone H2AR3me2s/H4R3me2s methylation (Fig. 4I) was barely detectable and heterogeneous. Yolk sac tumors teratomas and choriocarcinomas stained focally and cytoplasmatic for BLIMP1 and PRMT5 (not shown). Focal cytoplasmatic expression of BLIMP1 and PRMT5 was also observed in differentiated parts of teratoma, while chorioncarcinomas were negative for both proteins. A summary of the results of the immunohistochemical studies is given in Table 1.
###end p 20
###begin p 21
###xml 0 22 0 22 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Human germ cell tumors</bold>
###xml 68 71 68 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-C</bold>
###xml 84 87 84 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D-F</bold>
###xml 111 114 111 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G-I</bold>
###xml 136 137 136 137 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 139 140 139 140 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 142 143 142 143 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 153 154 153 154 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 156 157 156 157 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 163 164 163 164 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 198 199 198 199 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 201 202 201 202 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 204 205 204 205 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I</bold>
###xml 218 222 218 222 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-C </bold>
###xml 336 337 336 337 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 347 348 347 348 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 424 425 424 425 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 494 498 494 498 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D-F </bold>
###xml 638 639 638 639 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 756 757 756 757 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 767 769 767 769 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F </bold>
###xml 910 911 909 910 <bold xmlns:xlink="http://www.w3.org/1999/xlink">K</bold>
###xml 924 925 923 924 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L</bold>
###xml 1035 1041 1031 1037 <bold xmlns:xlink="http://www.w3.org/1999/xlink">M, N) </bold>
###xml 1071 1072 1067 1068 <bold xmlns:xlink="http://www.w3.org/1999/xlink">M</bold>
###xml 1085 1086 1081 1082 <bold xmlns:xlink="http://www.w3.org/1999/xlink">N</bold>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human germ cell tumors. Sections of neoplastic germ cells of IGCNU (A-C), seminoma (D-F), embryonal carcinoma (G-I) stained for BLIMP1 (A, D, G), PRMT5 (B, E, and H) and methylated histones H2A/H4 (C, F, I). In Figure A-C tubules with IGCNU are shown with consistent nuclear expression of BLIMP1 and Me H2A/H4 in neoplastic germ cells (A, BLIMP1; C, Me H2A/H4). PRMT5 is expressed in the cytoplasm of neoplastic germ cells (B). Notice that no expression is present in Sertoli cells. In Figures D-F expression in seminomas is presented. Notice the variation of the expression of BLIMP1, being low or moderate in the majority of the cells (D). PRMT5 is expressed in the cytoplasm of most seminoma cells, but some neoplastic cells also show nuclear staining (E). Figure F shows a strong nuclear staining of MeH2A/H4 in most seminoma cells. Size bar is 50 mum. Quantification of the relative expression of BLIMP1 (K) and PRMT5 (L) normalized to beta-Actin and compared to normal testicular tissue. Bars above the graph indicate p-values. (M, N) Expression values for BLIMP1 (M) and PRMT5 (N) from independent Affymetrix expression analyses (as referred in 23). Data are plotted as Log2 (y-axis) after normalization. Abbreviations: Normal testicular tissue (N), IGCNU, seminoma (SE), embryonal carcinoma (EC).
###end p 21
###begin p 22
Expression of BLIMP1, PRMT5 and dimethylated histone H4/H2A in normal and neoplastic testicular tissues
###end p 22
###begin p 23
N, number of cases; n, nuclear staining; c, cytoplasmatic staining
###end p 23
###begin p 24
+ weak; ++ moderate; +++, strong expression; -, no expression detectable
###end p 24
###begin p 25
*, only single tumor cells were detected as positive.
###end p 25
###begin p 26
###xml 407 409 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4K</xref>
###xml 712 714 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4L</xref>
###xml 810 812 807 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 861 863 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4M</xref>
###xml 868 870 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4N</xref>
In order to quantify the expression of BLIMP1 and PRMT5 we performed RT-PCR analyses on normal testicular tissue as well as on various TGCTs. The RNA levels measured were first normalized to betaActin and then calculated as relative expression with normal testicular tissue (N) set at 1. Expression of BLIMP1 was significantly higher in IGCNU (p = 0.029) containing testicular parenchyma and seminoma (Fig. 4K), but not in embryonal carcinoma (EC) (p = 0.16), which was comparable to normal testicular tissue. In contrast, PRMT5 was moderately higher in IGCNU (p = 0.033), while embryonal carcinoma (p = 0,091) and seminoma (p = 0,091) express a similar level of PRMT5 compared to normal testicular tissue (Fig. 4L). These data could be confirmed, using a whole genome expression DNA-Array as reported before [20]. Here, the same pattern was observed (see Fig. 4M and 4N).
###end p 26
###begin p 27
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A&#8211;C</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5E</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4M</xref>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4N</xref>
###xml 545 547 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 548 550 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5F</xref>
###xml 859 861 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5G</xref>
###xml 143 150 <span type="species:ncbi:9606">patient</span>
Finally, we asked whether BLIMP1/PRMT5 and modification of histone H2A and H4 could be detected in TCam-2, a cell line derived from a seminoma patient [21,22]. Here, we were able to detect BLIMP1 in the nucleus, PRMT5 in the nucleus and the cytoplasm (Fig. 5A-C). RT-PCR analyses showed that BLIMP1 and PRMT5 are expressed in TCam-2 cells (Fig. 5E) and absent JKT1 cells, in agreement with Affymetrix data (Fig. 4M and 4N). Of note, the findings on the JKT-1 cell line are in concordance with the conclusion that it is not a seminoma cell line [22,23]. Western blot analysis confirmed these results, showing that BLIMP1 and PRMT5, as well as the modified Histones H2A and H4 (Fig. 5F) can be detected. Next, we performed a CoIP on extracts from TCam-2 cells and were able to detect a signal for Blimp1 in material immunoprecipitated with PRMT5 antibody (Fig. 5G). This result demonstrates for the first time that PRMT-5 and BLIMP-1 interact biochemically.
###end p 27
###begin p 28
###xml 0 37 0 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Analysis of TCam-2 seminoma cell line</bold>
###xml 40 41 40 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 42 43 42 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 99 100 99 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 112 113 112 113 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 120 121 120 121 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 125 126 125 126 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 173 174 173 174 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 273 274 273 274 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 359 360 359 360 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 526 527 526 527 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 750 751 750 751 <bold xmlns:xlink="http://www.w3.org/1999/xlink">K</bold>
###xml 763 764 763 764 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I</bold>
###xml 771 772 771 772 <bold xmlns:xlink="http://www.w3.org/1999/xlink">M</bold>
###xml 776 777 776 777 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L</bold>
Analysis of TCam-2 seminoma cell line. (A-B) Immunohistochemistry using the antibodies indicated. (C) Merge of (A) and (B). (D) Counterstaining with DAPI to detect nuclei. (E) RT-PCR cell lines TCam2 and JKT1 as well as Testis detecting expression of the indicated genes. (F) Western Blot of protein lysate from TCam2 cells detecting the proteins indicated. (G) Co-IP experiment using antibody to PRMT5 for IP and antibody to BLIMP-1 to detect potential interaction. - no Antibodyl; + IP using PRMT5 Antibody; Input Control. (H) Co-IP experiment using antibody to PRMT7 for IP and antibody to BLIMP-1 to detect potential interaction. - no Antibodyl; + IP using PRMT5 Antibody; Input Control. (I-M) Immunohistochemistry using the PRMT7 antibody (I), (K) Merge of (I) and (M), (L) Counterstaining with DAPI to detect nuclei, (M) brightfield image. Scale Bar indicates 25 mum.
###end p 28
###begin p 29
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A&#8211;F</xref>
###xml 553 555 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4H</xref>
###xml 718 722 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4I&#8211;M</xref>
We had shown, that nuclear BLIMP1 and methylated H2A and H4 are expressed in IGCNU and seminoma, yet these cells express either little or cytoplasmic PRMT5 (Fig. 4A-F). We speculated that another methytransferase cooperating with BLIMP1 might be able to compensate PRMT5 function and help in establishing this methylation pattern. PRMT7 which is like PRMT5 a type II methyltransferase seemed a potential candidate since both PRMT5 and PRMT7 have been demonstrated to mediate symmetric arginine dimethylation of sm Proteins required for the spliceosome [24]. The CoIP experiment (Fig. 4H), demonstrates that BLIMP1 and PRMT7 interact biochemically. In addition PRMT7 shows a strong nuclear signal in TCam-2 cells (Fig. 4I-M). These results indicate that in germ cell tumors, both PRMT5 and PRMT7 might cooperate with BLIMP1 to establish dimethylation of H2A and H4.
###end p 29
###begin title 30
Discussion
###end title 30
###begin p 31
###xml 231 236 <span type="species:ncbi:9606">human</span>
In this study, we analyzed the expression of the putative inhibitor complex of germ cell differentiation BLIMP1 and PRMT5 on mRNA and protein level and the presence of the resulting repressive histone modifications H2A/H4R3me2s in human fetal and adult germ cells as well as TGCTs. We found BLIMP1 and PRMT5 localized in the nuclei of gonocytes, and the latter also in the cytoplasm, and could show the presence of the resulting dimethylation of H2A/H4 at arginine 3. In IGCNU a strong nuclear signal of BLIMP1 and of H2K3me2s/H4K3me2s was detected, whereas PRMT5 signal was cytoplasmatic in IGCNU and heterogeneous in seminomas.
###end p 31
###begin p 32
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 784 789 784 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HoxB1</italic>
###xml 849 856 849 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stella </italic>
###xml 897 899 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 954 978 954 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila melanogaster </italic>
###xml 996 1011 996 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Capsuleen/dart5</italic>
###xml 1071 1073 1071 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1074 1076 1074 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1185 1187 1185 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1232 1234 1232 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1235 1237 1235 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 37 43 <span type="species:ncbi:9606">humans</span>
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
###xml 198 203 <span type="species:ncbi:10090">mouse</span>
###xml 208 211 <span type="species:ncbi:9606">man</span>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
###xml 720 724 <span type="species:ncbi:10090">mice</span>
###xml 954 977 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 1369 1374 <span type="species:ncbi:9606">human</span>
The expression in fetal gonocytes in humans described here is in concordance to the observations made in mouse [17] indicating a conserved role of the nuclear localized BLIMP1/PRMT5 complex between mouse and man. Recently the transcriptional repressor BLIMP1 has been shown to be a crucial determinant of the germ cell lineage in mice [16]. This Kruppel-type zinc-finger containing protein interacts with the arginine methyl-transferase PRMT5 resulting in a symmetrical methylation at arginine 3 of histone H4 and H2A (H4R3me2s/H2Ame2s). The methylation in turn represses transcription[17] and therefore might be important for suppressing the somatic cell fate and keeping germ cells in a pluripotent state. In fact, in mice Blimp1-deficent germ cells show inconsistent repression of HoxB1, a hallmark of germ cell specification and fail to express Stella a marker of undifferentiated germ cells [16]. Also, recent studies showed, that abrogation of the Drosophila melanogaster homolog of PRMT5, Capsuleen/dart5, is essential for germ cell specification and maintenance [25,26]. Interestingly, Blimp1 expression is lost in PGCs which are cultured in the presence of basic FGF and LIF [15] and gradually become embryonic germ cells [27-29]. Hence the BLIMP1/PRMT5 interaction resulting in H2A/H4 modification might lead to repression of premature differentiation during human fetal germ cell development. As a consequence prolonged expression of BLIMP1/PRMT5 could result in persistence of undifferentiated gonocytes into adulthood.
###end p 32
###begin p 33
###xml 116 117 116 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 331 332 331 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 333 334 333 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
It is believed that those persisting gonocytes give rise to IGCNU the common precursor lesion of all type II TGCTs [4]. Indeed, we detected BLIMP1 protein and the characteristic modification of histones H2A and H4 not only in gonocytes but also in IGCNU and in seminoma supporting a PGC/gonocyte origin of IGCNU and therefore GCT [5,8,30,31]. PRMT5 however, is not detectable in nuclei of IGCNU, and displays only a sparse nuclear localization in seminoma cells. We found that another type II protein arginine methyltransferase, PRMT7 is expressed in TCAM2 seminoma cells and that PRMT7 interacts with BLIMP1 as well. So we speculate that in IGCNU and seminoma, BLIMP1 recruits PRMT7 to compensate for the lack of nuclear PRMT5 to mediate H2A and H4 dimethylation.
###end p 33
###begin p 34
Upon progression of IGCNU to nonseminomas signal intensity of BLIMP1 decreased and subcellular localization changed. As a consequence, H2A/H4 modification decreased and became heterogeneous in nonseminomas. Hence, the loss of the repressive histone modifications allows further uncontrolled differentiation observed in nonseminomas.
###end p 34
###begin title 35
Conclusion
###end title 35
###begin p 36
Taken together we propose the following model for development of germ cell neoplasia. First, coexpression and nuclear localization of the BLIMP1/PRMT5 complex leads to histone H2A/H4 dimethylation which results in transcriptional silencing of genes responsible for somatic differentiation in PGCs. Upon differentiation to prespermatogonia, this complex is downregulated and the H2A/H4 marks are lost. Aberrant constitutive histone H2A/H4 arginine 3 dimethylation allows the cells to escape the regular differentiation program resulting in their persistence into adulthood. These cells eventually progress into IGCNU, displaying the H2A/H4R3me2s modification as well. Since the subcellular localization of PRMT5 excludes PRMT5-dependent histone H2A/H4 modification in IGCNU we propose that BLIMP1 might act in cooperation with PRMT7. This mechanism persists in seminoma where the H2A/H4R3me2s modifications can be observed which explains the undifferentiated nature of the tumor cells. Translocation of BLIMP1 into the cytoplasm leads to breakdown of histone H2A/H4 dimethylation and subsequently to the activation of the differentiation programs and therefore the conversion from IGCNU into a nonseminomatous germ cell tumors.
###end p 36
###begin title 37
Methods
###end title 37
###begin title 38
Sample Handling and Characterization
###end title 38
###begin p 39
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 695 697 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 709 711 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 777 779 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 780 782 780 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Formalin fixed, paraffin embedded testicular tissues from 46 patients with GCTs (20 seminomas, 15 embryonic carcinomas, 5 Teratomas, 3 yolk sac tumors and 3 choriocarcinomas were collected for this study from archives of Departments of Pathology of University Medical Centers Bonn. Adjacent testicular parenchyma containing IGCNU were studied in 15 cases[32]. All tumors were classified according to the WHO classification of tumors based on their histology by two independent pathologists. Fresh frozen samples of each of normal testicular tissues (n = 3), seminoma (n = 3), mixed germ cell tumors (n = 3), IGCNU (n = 5) and embryonal carcinomas (EC) (n = 3), as well as RNA extracts of TCam2 [33] and JKT-1[34] cell lines, of which TCam2 resembles a seminoma-like cell-line [21-23], were additionally available for this study. Use of the tissue for scientific purposes was approved by the Institutional Regional Committee for Ethics.
###end p 39
###begin title 40
RT-PCR and quantitative image analysis
###end title 40
###begin p 41
###xml 274 279 274 279 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12&#8211;18</sub>
###xml 438 445 438 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLIMP1 </italic>
###xml 476 483 476 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLIMP1 </italic>
###xml 515 521 515 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRMT5 </italic>
###xml 552 558 552 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRMT5 </italic>
###xml 590 595 590 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH</italic>
###xml 632 639 632 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH R</italic>
Total RNA from at least three samples per tumor entity was extracted with TRIzol (Invitrogen, Karlsruhe, Germany) according to manufacturer's instruction. cDNA-syntesis was performed using SuperScript III reverse transcriptase (Invitrogen, Karlsruhe, Germany) and Oligo d(T)12-18(Invitrogen, Karlsruhe, Germany) and 100 ng of total RNA according to manufacturers instructions. PCRs were carried out in triplicates with following Primers: BLIMP1 F: 5'-GGGTGCAGCCTTTATGAGTC-3'; BLIMP1 R: 5'-CCTTGTTCA TGCCCTGAGAT-3'; PRMT5 F: 5'TTGCCGGC TACTTTGAGACT-3'; PRMT5 R: 5'-AAGGCAGGA AAGCAGATTGA-3'; GAPDH-F: 5'-TGGTATCGTGGAA GGACTCATG AC-3; GAPDH R: 5'-ATGCC AGTGAGCTTCCCGTTCAGC-3'. (beta-Act: 25 cycles BLIMP1 and PRMT5: 30 cycles). After agarose gel electrophoresis of the PCR-products band intensity was measured after RT-PCR with the image analysis software ImageJ 1.37 v (National Institutes of Health, USA, ) in triplicates and normalized to the according GAPDH band.
###end p 41
###begin title 42
Co-Immunoprecipitation
###end title 42
###begin p 43
###xml 34 38 34 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
Co-IP was performed with DYNABEADS(R) (Invitrogen, Carlsbad, USA) following manufacturers instructions. Immunopreciptation was performed with 1,5 mug anti-PRMT5 antibody (Chemicon, Temecula, USA) or anti-PRMT7 (Abcam, Cambrigde UK, 1:250). Western Blot with anti-BLIMP1 antibody followed (provided by H. M. Jack).
###end p 43
###begin title 44
Western Blot
###end title 44
###begin p 45
###xml 633 639 <span type="species:ncbi:9986">rabbit</span>
###xml 650 655 <span type="species:ncbi:10090">mouse</span>
For protein analysis Mini-PROTEAN Electrophoresis Cell and Mini Trans-Blot system was used (BioRad, Munich, Germany). Proteins were isolated using RIPA-buffer and prepared using standard protocol and finaly electrophoresed at 30 mA for 90 min. The gel was blotted onto a PVDF membrane in a BioRad blotting chamber overnight at 30 V at 4degreesC according to published protocols. After blocking in PBSTM (PBS, 0.1% v/v Tween 20, 5% low fat milk powder) primary antibodies (anti-BLIMP1 1:400 (kind gift from H. Jack), anti-PRMT5 1:200, Chemicon International, USA) were incubated in PBSTM for 3 h at RT. The secondary antibodies (anti-rabbit-HRP, anti-mouse-HRP: DAKO, Hamburg, Germany) were diluted 1:2000. Finally the membrane was incubated in 2 ml PierceSuper Signal West Pico chemiluminescent substrate (Perbio, Bonn, Germany) and the signal was detected using Kodak X-Ray film (Kodak, Stuttgart, Germany).
###end p 45
###begin title 46
Array Analysis
###end title 46
###begin p 47
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
DNA Array Dataset used to analyze BLIMP1/PRMT5 expression in Seminoma, embryonal carcinoma, TCam2 and JKT1 were generated as described [32].
###end p 47
###begin title 48
Immunohistochemistry
###end title 48
###begin p 49
###xml 531 532 530 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 598 599 597 598 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 600 602 599 601 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
For immunohistochemistry on paraffin-embedded tissue, dewaxed, 4-mum thick tissue sections were microwave-pretreated in citrate-buffer. Primary antibodies to PRMT5 (Upstate, Charlottesville, VA, 1:500), PRMT7 (Abcam, Cambrigde UK, 1:250) BLIMP1 (provided by H-M. Jack, University of Erlangen, Germany 1:500) and H2AR3me2s/H4R3me2s (Abcam, Cambridge, UK, 1:2000) were used for detection. Immunohistochemistry was performed using the DAKO EnVision-AEC Kit and manufacturers protocol (DAKO, Hamburg, Germany) as previously described [7]. Briefly, endogenous peroxidase was blocked for 5 min in 0.03% H2O2 (diluted in distilled water). Sections were washed in Tris-buffered saline (TBS; 0.05 M Tris and 0.85% NaCl, pH 7.6) and incubated with primary antibodies overnight at 4degreesC. Thereafter, a HRP-labeled polymer conjugated with a secondary antibody was applied (DAKO EnVision-AEC KIT). Pictures were taken using a Leica microscope fitted with a JVC digital camera (Leica, Bensheim, Germany). Figures were assembled using Adobe CS3 software package. Merge of pictures was performed using ImageJ (NIH, US).
###end p 49
###begin title 50
Authors' contributions
###end title 50
###begin p 51
DE, KB, DN, AG performed experiments, AG, HMJ, AMM and LL contributed material, KS helped in analysis of the Immunohistochemistry. DE, KB and HS conceived the experiments. DE, KB, LL and HS wrote the manuscript. All authors have seen and approved the final version.
###end p 51
###begin title 52
Acknowledgements
###end title 52
###begin p 53
We thank Gerrit Klemm and his Fotolab-Crew of the Foto- and Mediencenter and Wiebke Jeske for technical assistance. Grant support: This work was supported by the Deutsche Forschungsgemeinschaft (DFG 503/7 to H.S. and DFG 1265/1 to K.B.).
###end p 53
###begin article-title 54
Testicular cancer: current update and controversies
###end article-title 54
###begin article-title 55
###xml 64 67 <span type="species:ncbi:9606">men</span>
Increasing incidence of testicular germ cell tumors among black men in the United States
###end article-title 55
###begin article-title 56
Testicular germ-cell tumours in a broader perspective
###end article-title 56
###begin article-title 57
Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma
###end article-title 57
###begin article-title 58
Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells
###end article-title 58
###begin article-title 59
OCT4: A sensitive and specific biomarker for intratubular germ cell neoplasia of the testis
###end article-title 59
###begin article-title 60
###xml 61 66 <span type="species:ncbi:9606">human</span>
Spatial expression of germ cell markers during maturation of human fetal male gonads: an immunohistochemical study
###end article-title 60
###begin article-title 61
###xml 70 75 <span type="species:ncbi:9606">human</span>
Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads
###end article-title 61
###begin article-title 62
###xml 63 68 <span type="species:ncbi:9606">human</span>
POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors
###end article-title 62
###begin article-title 63
###xml 53 58 <span type="species:ncbi:9606">human</span>
The pluripotency homeobox gene NANOG is expressed in human germ cell tumors
###end article-title 63
###begin article-title 64
###xml 17 22 <span type="species:ncbi:9606">human</span>
Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture
###end article-title 64
###begin article-title 65
Transcription factor AP-2 essential for cranial closure and craniofacial development
###end article-title 65
###begin article-title 66
Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications
###end article-title 66
###begin article-title 67
###xml 10 15 <span type="species:ncbi:9606">Human</span>
The Early Human Germ Cell Lineage Does Not Express SOX2 During In Vivo Development or Upon In Vitro Culture
###end article-title 67
###begin article-title 68
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Germ cell specification in mice
###end article-title 68
###begin article-title 69
###xml 61 65 <span type="species:ncbi:10090">mice</span>
Blimp1 is a critical determinant of the germ cell lineage in mice
###end article-title 69
###begin article-title 70
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells
###end article-title 70
###begin article-title 71
###xml 55 60 <span type="species:ncbi:9606">Human</span>
Immunohistochemical Profiling of Germ Cells Within the Human Fetal Testis: Identification of Three Subpopulations
###end article-title 71
###begin article-title 72
###xml 74 79 <span type="species:ncbi:9606">human</span>
A monoclonal antibody as a marker for carcinoma in situ germ cells of the human adult testis
###end article-title 72
###begin article-title 73
###xml 36 41 <span type="species:ncbi:9606">human</span>
Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene
###end article-title 73
###begin article-title 74
Further characterization of the first seminoma cell line TCam-2
###end article-title 74
###begin article-title 75
TCam-2 but not JKT-1 cells resemble seminoma in cell culture
###end article-title 75
###begin article-title 76
###xml 15 20 <span type="species:ncbi:9606">human</span>
JKT-1 is not a human seminoma cell line
###end article-title 76
###begin article-title 77
Two distinct arginine methyltransferases are required for biogenesis of Sm-class ribonucleoproteins
###end article-title 77
###begin article-title 78
Arginine methyltransferase Capsuleen is essential for methylation of spliceosomal Sm proteins and germ cell formation in Drosophila
###end article-title 78
###begin article-title 79
The Sm-protein methyltransferase, dart5, is essential for germ-cell specification and maintenance
###end article-title 79
###begin article-title 80
The role of exogenous fibroblast growth factor-2 on the reprogramming of primordial germ cells into pluripotent stem cells
###end article-title 80
###begin article-title 81
###xml 55 61 <span type="species:ncbi:10090">murine</span>
Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture
###end article-title 81
###begin article-title 82
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
Long-term proliferation of mouse primordial germ cells in culture
###end article-title 82
###begin article-title 83
Immunohistochemical markers of carcinoma in situ of the testis also expressed in normal infantile germ cells
###end article-title 83
###begin article-title 84
Angiotensin-converting enzyme (CD143) in neoplastic germ cells
###end article-title 84
###begin article-title 85
###xml 99 104 <span type="species:ncbi:9606">human</span>
Aberrant platelet-derived growth factor alpha-receptor transcript as a diagnostic marker for early human germ cell tumors of the adult testis
###end article-title 85
###begin article-title 86
###xml 45 50 <span type="species:ncbi:9606">human</span>
[Establishment and characterization of a new human testicular germ cell tumor cell line (TCam-2)]
###end article-title 86
###begin article-title 87
###xml 44 49 <span type="species:ncbi:9606">human</span>
Establishment and characterization of a new human testicular seminoma cell line, JKT-1
###end article-title 87

